Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Thomas Campbell

Concepts (610)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
109
2024
2453
6.840
Why?
Sarcoma, Kaposi
23
2024
68
5.340
Why?
HIV-1
61
2023
768
4.910
Why?
Anti-HIV Agents
46
2023
663
4.320
Why?
Herpesvirus 8, Human
22
2024
61
3.510
Why?
Antiretroviral Therapy, Highly Active
30
2023
256
2.650
Why?
AIDS-Related Opportunistic Infections
12
2021
115
1.850
Why?
Anti-Retroviral Agents
20
2019
207
1.830
Why?
Viral Load
34
2023
405
1.500
Why?
Acquired Immunodeficiency Syndrome
7
2023
212
1.470
Why?
HIV Seropositivity
7
2021
109
1.400
Why?
Zimbabwe
17
2023
41
1.350
Why?
International Cooperation
4
2018
169
1.240
Why?
CD4 Lymphocyte Count
26
2023
256
1.100
Why?
Education, Medical
3
2018
214
1.060
Why?
Aging
8
2020
1611
1.000
Why?
RNA, Viral
19
2014
565
0.940
Why?
Physical Fitness
2
2015
180
0.870
Why?
Male
110
2023
55396
0.840
Why?
Adult
92
2023
30375
0.830
Why?
DNA, Viral
12
2013
349
0.830
Why?
Tuberculosis
7
2023
241
0.820
Why?
Humans
153
2024
114045
0.810
Why?
Middle Aged
69
2023
26605
0.800
Why?
Drug Resistance, Viral
8
2015
99
0.780
Why?
Antibodies, Viral
8
2023
520
0.780
Why?
Viremia
6
2011
122
0.770
Why?
Herpesviridae Infections
7
2021
138
0.760
Why?
Female
104
2023
59324
0.750
Why?
CD4-Positive T-Lymphocytes
12
2023
959
0.730
Why?
Coinfection
6
2019
120
0.720
Why?
AIDS Dementia Complex
7
2015
50
0.710
Why?
Nursing Staff, Hospital
1
2022
123
0.680
Why?
Granulocyte Colony-Stimulating Factor
4
2004
70
0.670
Why?
Reverse Transcriptase Inhibitors
6
2015
82
0.660
Why?
Lamivudine
6
2017
59
0.650
Why?
Lipopolysaccharide Receptors
2
2021
81
0.640
Why?
Hematopoietic Stem Cell Mobilization
3
2004
20
0.640
Why?
Anemia
3
2023
143
0.630
Why?
Inflammation
14
2023
2464
0.630
Why?
Vitamin D Deficiency
3
2017
158
0.620
Why?
Vitamin D
5
2018
340
0.600
Why?
HIV
8
2023
208
0.590
Why?
Plasma
4
2015
181
0.560
Why?
Prospective Studies
21
2022
6195
0.540
Why?
Micronutrients
4
2018
77
0.540
Why?
Burnout, Professional
1
2022
323
0.540
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
2
2023
20
0.530
Why?
Health Resources
5
2019
120
0.520
Why?
Internationality
5
2019
143
0.510
Why?
Motor Activity
3
2015
635
0.510
Why?
Quality of Life
6
2019
2343
0.510
Why?
Developing Countries
10
2020
231
0.510
Why?
RNA, Catalytic
4
1997
181
0.490
Why?
Awareness
1
2015
93
0.480
Why?
Antibiotics, Antineoplastic
3
2023
110
0.470
Why?
Benzoxazines
6
2017
28
0.470
Why?
Zidovudine
7
2017
77
0.460
Why?
C-Reactive Protein
5
2015
362
0.450
Why?
Biomarkers
13
2023
3397
0.450
Why?
HIV Integrase Inhibitors
1
2015
62
0.450
Why?
Bronchoalveolar Lavage Fluid
6
2021
580
0.440
Why?
Monocytes
2
2023
503
0.430
Why?
Gastrointestinal Microbiome
4
2021
502
0.430
Why?
Cytomegalovirus Infections
1
2015
180
0.420
Why?
Treatment Outcome
21
2021
9049
0.420
Why?
Immune Reconstitution Inflammatory Syndrome
4
2020
18
0.410
Why?
Malnutrition
3
2018
62
0.390
Why?
Aged
23
2023
18969
0.390
Why?
Sarcopenia
1
2013
63
0.390
Why?
Receptors, CCR5
5
2021
54
0.380
Why?
Faculty, Medical
4
2018
226
0.370
Why?
Cross-Sectional Studies
10
2022
4402
0.360
Why?
Homosexuality, Male
4
2021
169
0.350
Why?
Accidental Falls
1
2012
151
0.350
Why?
Virus Replication
6
2006
395
0.350
Why?
South America
7
2020
52
0.350
Why?
Osteoporosis
1
2013
224
0.350
Why?
Antiviral Agents
5
2017
642
0.350
Why?
Africa
6
2020
92
0.340
Why?
Neutropenia
1
2010
123
0.340
Why?
Tenofovir
6
2017
204
0.340
Why?
Sexual Behavior
4
2020
434
0.340
Why?
Antineoplastic Agents, Phytogenic
3
2020
181
0.330
Why?
Drug Therapy, Combination
10
2020
949
0.330
Why?
Health Services Accessibility
1
2015
756
0.330
Why?
Advance Care Planning
1
2012
195
0.320
Why?
Drug Monitoring
1
2010
184
0.320
Why?
Viral Proteins
2
2008
281
0.310
Why?
Thrombocytopenia
1
2010
177
0.310
Why?
Emergency Medical Services
1
2015
581
0.310
Why?
Sexual and Gender Minorities
3
2021
138
0.310
Why?
Sex Characteristics
3
2023
636
0.300
Why?
Genetic Variation
4
2008
868
0.300
Why?
Microbiota
4
2018
648
0.300
Why?
Cohort Studies
20
2019
4883
0.300
Why?
Pharmacogenetics
3
2023
149
0.300
Why?
Professional Competence
2
2018
81
0.290
Why?
Health Knowledge, Attitudes, Practice
1
2015
1168
0.290
Why?
Etoposide
4
2023
149
0.290
Why?
CD8-Positive T-Lymphocytes
4
2021
686
0.280
Why?
Schools, Medical
2
2018
121
0.280
Why?
Atazanavir Sulfate
3
2016
41
0.280
Why?
Survival Analysis
4
2015
1206
0.280
Why?
Cyclopropanes
6
2017
81
0.280
Why?
Young Adult
19
2023
10444
0.280
Why?
Alkynes
6
2017
53
0.280
Why?
Sex Factors
4
2016
1706
0.270
Why?
Macrophages, Alveolar
2
2020
348
0.270
Why?
Asia
5
2016
53
0.270
Why?
Pregnancy Complications, Infectious
3
2018
285
0.260
Why?
Needs Assessment
2
2018
315
0.260
Why?
Genotype
7
2023
1757
0.250
Why?
Treatment Failure
8
2018
330
0.250
Why?
Case-Control Studies
8
2018
3003
0.250
Why?
Risk Factors
16
2023
8614
0.250
Why?
Drug Resistance, Multiple, Viral
1
2005
11
0.250
Why?
Body Composition
2
2020
590
0.250
Why?
Proportional Hazards Models
7
2018
1078
0.240
Why?
Disease Progression
9
2021
2371
0.240
Why?
Curriculum
4
2018
813
0.240
Why?
Immune System Diseases
1
2004
32
0.240
Why?
Salvage Therapy
1
2005
127
0.230
Why?
Lymph Nodes
3
2011
415
0.230
Why?
Virus Latency
1
2004
80
0.230
Why?
Dideoxynucleosides
2
2014
20
0.220
Why?
Feces
4
2021
372
0.220
Why?
United States
9
2023
12137
0.220
Why?
Lung
8
2022
3521
0.210
Why?
Prevalence
9
2019
2247
0.210
Why?
Insulin-Like Growth Factor I
2
2017
286
0.210
Why?
Program Evaluation
2
2018
820
0.210
Why?
Intestinal Mucosa
2
2021
532
0.210
Why?
Surveys and Questionnaires
5
2022
4595
0.210
Why?
Adolescent
16
2023
17800
0.210
Why?
Cardiotoxicity
1
2023
27
0.210
Why?
Heart Injuries
1
2023
37
0.210
Why?
Interleukin-10
2
2023
293
0.210
Why?
Incidence
7
2023
2314
0.210
Why?
ADP-ribosyl Cyclase 1
2
2013
36
0.200
Why?
Plaque, Atherosclerotic
1
2023
46
0.200
Why?
Neurocognitive Disorders
2
2019
22
0.200
Why?
Nevirapine
2
2013
16
0.200
Why?
Lymphocytes
2
2023
327
0.200
Why?
Cognition
4
2017
990
0.200
Why?
Myocarditis
1
2023
93
0.200
Why?
Emtricitabine
4
2017
147
0.200
Why?
Personnel Turnover
1
2022
27
0.190
Why?
Polymerase Chain Reaction
6
2021
990
0.190
Why?
Gastrointestinal Tract
2
2014
169
0.190
Why?
Immunogenicity, Vaccine
1
2021
25
0.190
Why?
Doxorubicin
1
2023
286
0.190
Why?
Longitudinal Studies
9
2019
2384
0.190
Why?
Selenium
3
2018
31
0.190
Why?
B-Cell Maturation Antigen
1
2021
4
0.190
Why?
Pilot Projects
5
2014
1360
0.180
Why?
Multivariate Analysis
4
2015
1422
0.180
Why?
Firmicutes
1
2021
17
0.180
Why?
Leadership
3
2018
291
0.180
Why?
Exercise
2
2021
1642
0.180
Why?
Intention
1
2022
142
0.180
Why?
Odds Ratio
2
2014
951
0.180
Why?
Weight Loss
3
2020
642
0.180
Why?
Filgrastim
4
2004
10
0.170
Why?
Job Satisfaction
1
2022
168
0.170
Why?
T-Lymphocytopenia, Idiopathic CD4-Positive
1
2020
7
0.170
Why?
Hematopoietic Stem Cells
2
2000
338
0.170
Why?
Workplace
1
2022
221
0.170
Why?
Leukapheresis
1
2000
21
0.170
Why?
Membrane Glycoproteins
2
2013
429
0.170
Why?
Bacteria
3
2018
725
0.170
Why?
Suicide
2
2017
507
0.170
Why?
Vincristine
1
2020
98
0.170
Why?
B-Lymphocytes
1
2004
762
0.170
Why?
Pyridazines
2
2012
46
0.170
Why?
Multiple Myeloma
1
2021
98
0.170
Why?
Violence
1
2022
201
0.160
Why?
Brain
4
2019
2355
0.160
Why?
Clinical Trials as Topic
2
2016
926
0.160
Why?
Peripheral Nervous System Diseases
1
2020
120
0.160
Why?
Germ-Free Life
1
2019
28
0.160
Why?
Atherosclerosis
1
2023
342
0.160
Why?
T-Lymphocytes, Regulatory
1
2021
337
0.160
Why?
Hexosaminidases
1
2019
17
0.160
Why?
Early Detection of Cancer
1
2022
305
0.160
Why?
Immunotherapy, Adoptive
1
2021
184
0.160
Why?
Urban Population
2
2013
396
0.160
Why?
Prevotella
1
2018
12
0.160
Why?
Cerebral Cortex
2
2013
380
0.160
Why?
Basal Ganglia
3
2014
44
0.150
Why?
Bleomycin
1
2020
228
0.150
Why?
Mouth
2
2015
69
0.150
Why?
Organophosphonates
3
2013
89
0.150
Why?
AIDS Vaccines
1
2018
41
0.150
Why?
Genes, pol
3
2007
7
0.150
Why?
Follow-Up Studies
7
2021
4392
0.150
Why?
Drug Combinations
2
2017
286
0.150
Why?
Capacity Building
1
2018
51
0.140
Why?
Mutation
4
2015
3338
0.140
Why?
Cognitive Dysfunction
2
2019
282
0.140
Why?
Nucleic Acid Conformation
2
1997
670
0.140
Why?
HIV Protease Inhibitors
2
2016
64
0.140
Why?
Angiotensin Receptor Antagonists
1
2017
76
0.140
Why?
Vitamin A Deficiency
1
2017
27
0.140
Why?
Hospitals
1
2022
581
0.140
Why?
Didanosine
2
2014
13
0.140
Why?
Adenine
3
2013
218
0.140
Why?
Inflammation Mediators
2
2018
475
0.140
Why?
Herpesvirus 2, Human
1
2017
27
0.140
Why?
Anti-Inflammatory Agents
1
2020
445
0.140
Why?
Dysbiosis
2
2021
145
0.140
Why?
Coronary Artery Disease
1
2023
611
0.140
Why?
Financing, Organized
1
2017
33
0.140
Why?
Magnetic Resonance Spectroscopy
3
2014
474
0.140
Why?
Recombinant Proteins
4
2004
1228
0.140
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2017
180
0.130
Why?
Immunoglobulin G
2
2023
766
0.130
Why?
Africa South of the Sahara
4
2020
33
0.130
Why?
Kaplan-Meier Estimate
3
2013
813
0.130
Why?
Haiti
2
2016
10
0.130
Why?
Herpes Simplex
1
2017
87
0.130
Why?
Lymphocyte Activation
3
2018
1036
0.130
Why?
Genes, env
2
2007
4
0.130
Why?
Nervous System Diseases
1
2019
254
0.130
Why?
Tetrahymena thermophila
1
1996
58
0.130
Why?
Pregnancy Outcome
1
2018
337
0.130
Why?
Muscle Strength
1
2018
271
0.130
Why?
Ghana
1
2015
30
0.130
Why?
Mental Status and Dementia Tests
1
2016
21
0.130
Why?
Up-Regulation
1
2019
802
0.130
Why?
Ambulances
1
2015
48
0.130
Why?
Molecular Sequence Data
6
2013
2783
0.130
Why?
DNA, Protozoan
1
2015
26
0.120
Why?
RNA, Protozoan
1
1995
55
0.120
Why?
Hepatitis B, Chronic
1
2015
18
0.120
Why?
Plasmodium falciparum
1
2015
27
0.120
Why?
Rhodobacter sphaeroides
3
1983
7
0.120
Why?
Exercise Therapy
1
2018
351
0.120
Why?
Chemokine CXCL10
1
2015
34
0.120
Why?
Time Factors
3
2015
6077
0.120
Why?
Malaria
1
2015
48
0.120
Why?
Research
1
2018
389
0.120
Why?
Cerebrospinal Fluid
1
2015
90
0.120
Why?
Pre-Exposure Prophylaxis
1
2017
179
0.120
Why?
Retroviridae Infections
1
1995
46
0.120
Why?
Randomized Controlled Trials as Topic
6
2015
1204
0.120
Why?
Bone Morphogenetic Proteins
1
2015
132
0.120
Why?
Phylogeny
3
2008
787
0.120
Why?
Cytomegalovirus
1
2015
143
0.120
Why?
Anthracyclines
1
2014
42
0.120
Why?
Health Occupations
1
2014
28
0.110
Why?
Education, Medical, Graduate
1
2018
366
0.110
Why?
Orchitis
1
2014
4
0.110
Why?
Penicillin G
1
2014
7
0.110
Why?
Caribbean Region
2
2011
19
0.110
Why?
Pregnancy
5
2018
5499
0.110
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2017
373
0.110
Why?
Health Care Surveys
1
2015
541
0.110
Why?
Suicidal Ideation
2
2017
402
0.110
Why?
Syphilis
1
2014
26
0.110
Why?
Infectious Disease Transmission, Vertical
2
2012
150
0.110
Why?
Stavudine
1
2013
8
0.110
Why?
Seroepidemiologic Studies
2
2015
137
0.110
Why?
Metabolic Diseases
1
2014
98
0.110
Why?
Aging, Premature
1
2013
11
0.110
Why?
Tropheryma
1
2013
5
0.110
Why?
Whipple Disease
1
2013
6
0.110
Why?
HIV Antigens
3
2015
17
0.110
Why?
Pyrrolidinones
1
2013
25
0.110
Why?
Biota
1
2013
35
0.110
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
38
0.110
Why?
Problem-Based Learning
1
2014
77
0.110
Why?
Genitalia, Male
1
2013
10
0.110
Why?
Body Fat Distribution
1
2013
46
0.110
Why?
Retinal Detachment
1
2014
52
0.110
Why?
Genetic Therapy
1
1995
256
0.110
Why?
Peptide Fragments
3
2007
665
0.110
Why?
Sequence Analysis, DNA
3
2013
722
0.110
Why?
Genitalia, Female
1
2013
37
0.100
Why?
Hospitals, University
1
2013
169
0.100
Why?
Fever
2
2021
280
0.100
Why?
Weight Gain
1
2016
453
0.100
Why?
RNA Stability
1
2013
90
0.100
Why?
Hepatitis B
1
2013
51
0.100
Why?
Frail Elderly
1
2013
106
0.100
Why?
Metagenome
1
2013
121
0.100
Why?
Urinary Catheterization
1
1992
22
0.100
Why?
Prostatitis
1
1992
18
0.100
Why?
Aspergillosis
1
1992
23
0.100
Why?
Withholding Treatment
1
2012
66
0.100
Why?
Muscles
1
2013
320
0.100
Why?
Universities
1
2014
338
0.100
Why?
Movement
1
2014
242
0.100
Why?
Respiratory System
1
2013
137
0.100
Why?
Body Mass Index
3
2014
1957
0.100
Why?
Neuropsychological Tests
4
2019
926
0.100
Why?
Marijuana Smoking
1
2015
224
0.100
Why?
Body Weight
1
2016
868
0.100
Why?
Education, Medical, Undergraduate
1
2014
160
0.100
Why?
Catheters, Indwelling
1
1992
74
0.100
Why?
Lipopolysaccharides
1
2015
813
0.100
Why?
Breast Neoplasms
1
2023
1846
0.100
Why?
Unsafe Sex
1
2012
57
0.100
Why?
Confidence Intervals
1
2012
302
0.090
Why?
HIV Core Protein p24
3
2006
28
0.090
Why?
Paclitaxel
2
2020
190
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
907
0.090
Why?
Mycobacterium tuberculosis
2
2012
269
0.090
Why?
Disabled Persons
1
2013
130
0.090
Why?
Tumor Necrosis Factor-alpha
3
2022
1128
0.090
Why?
Exanthema
1
2012
74
0.090
Why?
Endothelial Cells
2
2024
677
0.090
Why?
CD4 Antigens
1
2011
123
0.090
Why?
Smoking
2
2020
1382
0.090
Why?
Piperazines
1
1993
310
0.090
Why?
Kidney Diseases
1
2014
349
0.090
Why?
Polyneuropathies
1
2011
50
0.090
Why?
Corpus Callosum
1
2011
56
0.090
Why?
Americas
1
2010
17
0.090
Why?
RNA, Ribosomal, 16S
3
2019
485
0.090
Why?
T-Lymphocyte Subsets
2
2011
383
0.090
Why?
Patient Compliance
1
2014
524
0.090
Why?
Specimen Handling
1
2011
153
0.090
Why?
Bone and Bones
1
2013
277
0.090
Why?
Interleukin-6
3
2022
673
0.090
Why?
HLA-DR Antigens
1
2011
219
0.090
Why?
Health Personnel
1
2016
569
0.090
Why?
Fluorescent Antibody Technique
3
2015
396
0.090
Why?
Antigens, Viral
2
2021
176
0.090
Why?
HIV Reverse Transcriptase
2
2004
29
0.080
Why?
Emigrants and Immigrants
1
2012
107
0.080
Why?
HIV Fusion Inhibitors
2
2007
3
0.080
Why?
HIV Envelope Protein gp41
2
2007
6
0.080
Why?
Bone Density
1
2013
432
0.080
Why?
RNA
1
1995
806
0.080
Why?
Lung Neoplasms
1
2021
2159
0.080
Why?
Tuberculosis, Pulmonary
2
2013
113
0.080
Why?
Metabolic Syndrome
1
2012
320
0.080
Why?
Neuroimaging
1
2011
249
0.080
Why?
Smokers
2
2020
129
0.080
Why?
Lung Diseases
1
2015
690
0.080
Why?
South Africa
3
2016
160
0.080
Why?
Socioeconomic Factors
1
2012
1080
0.080
Why?
Epitopes, T-Lymphocyte
2
2006
170
0.070
Why?
Cytokines
3
2021
1824
0.070
Why?
Uganda
1
2008
69
0.070
Why?
Leukocytes, Mononuclear
2
2021
489
0.070
Why?
Retrospective Studies
4
2023
12521
0.070
Why?
Base Composition
2
1997
75
0.070
Why?
Organizational Culture
2
2018
119
0.070
Why?
Sweating
1
2007
23
0.070
Why?
Colorado
3
2012
4090
0.070
Why?
Amino Acid Sequence
3
2006
1981
0.070
Why?
Blood Vessels
1
2008
179
0.070
Why?
Vitamin A
2
2018
52
0.070
Why?
Healthy Volunteers
2
2018
191
0.070
Why?
Gender Identity
1
2007
100
0.070
Why?
Purine Nucleosides
1
2006
3
0.070
Why?
Peru
2
2016
54
0.060
Why?
Dioxolanes
1
2006
6
0.060
Why?
Program Development
2
2018
339
0.060
Why?
Gene Products, gag
1
2006
36
0.060
Why?
Substrate Specificity
2
1997
350
0.060
Why?
DNA, Bacterial
3
2019
312
0.060
Why?
Phospholipids
3
1983
194
0.060
Why?
Logistic Models
3
2015
1829
0.060
Why?
Biopsy
2
2020
1024
0.060
Why?
Selection Bias
1
2005
33
0.060
Why?
Dizziness
2
2018
70
0.060
Why?
Disease Reservoirs
1
2004
19
0.060
Why?
Double-Blind Method
3
2018
1656
0.060
Why?
Anti-Bacterial Agents
1
2014
1471
0.060
Why?
HIV Protease
1
2004
3
0.060
Why?
Comorbidity
1
2009
1447
0.060
Why?
Linear Models
3
2011
768
0.060
Why?
HIV Envelope Protein gp120
1
2004
56
0.060
Why?
WT1 Proteins
1
2024
12
0.060
Why?
CASP8 and FADD-Like Apoptosis Regulating Protein
1
2024
20
0.060
Why?
Base Sequence
3
1996
2114
0.060
Why?
Syndrome
1
2004
330
0.060
Why?
Castleman Disease
1
2003
12
0.060
Why?
Matrix Metalloproteinase 2
1
2023
56
0.050
Why?
Aspartic Acid
2
2014
77
0.050
Why?
Magnetic Resonance Imaging
2
2011
3039
0.050
Why?
United Kingdom
2
2014
226
0.050
Why?
Endemic Diseases
1
2003
23
0.050
Why?
Glucuronosyltransferase
1
2023
9
0.050
Why?
Polymorphism, Single Nucleotide
2
2023
1880
0.050
Why?
Reference Values
2
2016
739
0.050
Why?
Receptors, Tumor Necrosis Factor
1
2023
140
0.050
Why?
Choline
2
2014
106
0.050
Why?
Binding Sites
2
1996
1166
0.050
Why?
Protein Isoforms
1
2024
337
0.050
Why?
Interferon-gamma
1
2006
719
0.050
Why?
Cardiovascular Diseases
1
2013
1726
0.050
Why?
Chemoradiotherapy
1
2023
187
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
924
0.050
Why?
Lopinavir
2
2013
29
0.050
Why?
Deoxycytidine
2
2014
138
0.050
Why?
Reproducibility of Results
3
2008
2764
0.050
Why?
Antibodies, Neutralizing
1
2023
222
0.050
Why?
Ligands
1
2023
556
0.050
Why?
Intention to Treat Analysis
1
2021
69
0.050
Why?
Patient Acuity
1
2021
42
0.050
Why?
Ritonavir
2
2013
71
0.050
Why?
Frontal Lobe
2
2014
141
0.050
Why?
Hemoglobins
1
2023
308
0.050
Why?
Immunization, Secondary
1
2021
82
0.050
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2021
34
0.050
Why?
Vidarabine
1
2021
26
0.050
Why?
T-Lymphocytes, Cytotoxic
1
2001
154
0.050
Why?
Tumor Microenvironment
1
2024
428
0.050
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2021
73
0.050
Why?
Regression Analysis
2
2014
945
0.050
Why?
Single-Blind Method
1
2021
259
0.050
Why?
Vascular Endothelial Growth Factor A
1
2023
496
0.050
Why?
Sensitivity and Specificity
2
2007
1690
0.040
Why?
Cyclophosphamide
1
2021
214
0.040
Why?
Cell Line
3
2001
2629
0.040
Why?
Cells, Cultured
4
2008
3861
0.040
Why?
Cough
1
2021
107
0.040
Why?
Integrin alpha Chains
1
2020
22
0.040
Why?
Genome, Bacterial
1
2021
106
0.040
Why?
Echocardiography
1
2023
569
0.040
Why?
Fatty Acids
1
1983
380
0.040
Why?
Enzyme-Linked Immunosorbent Assay
2
2015
787
0.040
Why?
Brazil
2
2016
89
0.040
Why?
Virion
1
2000
73
0.040
Why?
Antigens, CD34
1
2000
88
0.040
Why?
Immunophenotyping
1
2020
274
0.040
Why?
Immunologic Memory
1
2001
313
0.040
Why?
Research Design
1
2005
919
0.040
Why?
Nitriles
2
2012
149
0.040
Why?
Animals
5
2019
31565
0.040
Why?
Diffusion Tensor Imaging
1
2019
63
0.040
Why?
Atrophy
1
2019
152
0.040
Why?
Teacher Training
1
2018
6
0.040
Why?
Motor Skills
1
2019
82
0.040
Why?
Genes, vpr
1
1997
1
0.040
Why?
Genes, vif
1
1997
3
0.040
Why?
Aspartate Aminotransferases
1
2018
85
0.040
Why?
Trace Elements
1
2018
45
0.040
Why?
Stillbirth
1
2018
57
0.040
Why?
Back Pain
1
2018
44
0.040
Why?
Colon
1
2020
232
0.040
Why?
Macaca mulatta
1
2018
131
0.040
Why?
Colony Count, Microbial
1
2018
111
0.040
Why?
Cytochrome P-450 CYP2B6
1
2017
9
0.040
Why?
DNA Primers
2
1996
508
0.040
Why?
Cytochrome P-450 CYP2A6
1
2017
9
0.040
Why?
Adenoviridae
1
2018
184
0.040
Why?
Principal Component Analysis
1
2018
177
0.040
Why?
Antigens, CD
1
2020
440
0.040
Why?
Immunity, Humoral
1
2018
112
0.040
Why?
Diarrhea
1
2018
170
0.040
Why?
Abdominal Pain
1
2018
134
0.040
Why?
In Vitro Techniques
1
2019
1003
0.040
Why?
Genetic Vectors
1
2018
287
0.030
Why?
Toll-Like Receptors
1
2018
167
0.030
Why?
Pyrimidines
2
2012
374
0.030
Why?
Immunosuppressive Agents
1
2021
641
0.030
Why?
Seroconversion
1
2017
45
0.030
Why?
Benzoxazoles
1
1996
16
0.030
Why?
Oligoribonucleotides
1
1996
52
0.030
Why?
Immunity, Cellular
1
2018
247
0.030
Why?
Fatigue
1
2018
294
0.030
Why?
Life Style
1
2018
428
0.030
Why?
Thailand
1
2016
9
0.030
Why?
Gene Frequency
1
2017
476
0.030
Why?
Patient Selection
1
2000
629
0.030
Why?
Age Factors
2
2016
2885
0.030
Why?
Malawi
1
2016
45
0.030
Why?
Administration, Oral
1
2018
725
0.030
Why?
Nutritional Status
1
2018
286
0.030
Why?
India
1
2016
134
0.030
Why?
Catalysis
1
1996
289
0.030
Why?
Verbal Learning
1
2016
63
0.030
Why?
Parasitemia
1
2015
9
0.030
Why?
Human Activities
1
2015
18
0.030
Why?
Hepatitis B virus
1
2015
25
0.030
Why?
Nuclear Proteins
1
1999
591
0.030
Why?
Pyridones
1
1996
122
0.030
Why?
Fellowships and Scholarships
1
2018
224
0.030
Why?
pol Gene Products, Human Immunodeficiency Virus
1
2015
1
0.030
Why?
Vaccination
1
2023
1202
0.030
Why?
RNA Splicing
1
1996
244
0.030
Why?
Carotenoids
1
2015
33
0.030
Why?
Chronic Disease
2
2014
1577
0.030
Why?
Tetrahymena
1
1995
155
0.030
Why?
Premature Birth
1
2018
275
0.030
Why?
Genotyping Techniques
1
2015
69
0.030
Why?
Placebos
1
2015
197
0.030
Why?
Vitamin E
1
2015
110
0.030
Why?
Schools, Health Occupations
1
2014
6
0.030
Why?
Retreatment
1
2014
67
0.030
Why?
Developed Countries
1
2014
25
0.030
Why?
World Health Organization
1
2014
101
0.030
Why?
Genetic Markers
1
2015
320
0.030
Why?
Dose-Response Relationship, Drug
1
2018
1836
0.030
Why?
Ophthalmoscopy
1
2014
30
0.030
Why?
Creatine
1
2014
51
0.030
Why?
Skin
1
2018
653
0.030
Why?
Psychology
1
2014
82
0.030
Why?
Phenotype
2
2014
2784
0.030
Why?
Protons
1
2014
73
0.030
Why?
Diffusion of Innovation
1
2014
91
0.030
Why?
Educational Status
1
2016
408
0.030
Why?
Group Processes
1
2014
53
0.030
Why?
Gray Matter
1
2014
67
0.030
Why?
DNA, Ribosomal
1
2013
79
0.030
Why?
Raltegravir Potassium
1
2013
16
0.030
Why?
Global Health
1
2015
284
0.030
Why?
Inositol
1
2013
23
0.030
Why?
Bronchoalveolar Lavage
1
2013
82
0.030
Why?
Programmed Cell Death 1 Receptor
1
2015
193
0.030
Why?
Hepatitis B Surface Antigens
1
2013
18
0.030
Why?
Kinetics
1
1996
1547
0.030
Why?
Oligopeptides
1
2014
234
0.030
Why?
Polymorphism, Genetic
1
2016
610
0.030
Why?
White Matter
1
2014
105
0.030
Why?
Hypertension, Pulmonary
1
2003
1736
0.030
Why?
Gene Expression Regulation
2
2014
2322
0.030
Why?
Adaptor Proteins, Signal Transducing
1
2015
367
0.030
Why?
Kidney Failure, Chronic
1
2017
489
0.030
Why?
Cause of Death
1
2014
362
0.030
Why?
Medication Adherence
1
2017
531
0.030
Why?
Risk
1
2015
810
0.020
Why?
Microbial Sensitivity Tests
1
1993
300
0.020
Why?
Hospitalization
1
2021
1762
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1356
0.020
Why?
Visual Acuity
1
2014
272
0.020
Why?
Neurologic Examination
1
2012
113
0.020
Why?
Blood Coagulation
1
2013
200
0.020
Why?
Receptors, HIV
1
2011
23
0.020
Why?
Cooperative Behavior
1
2014
376
0.020
Why?
Psychological Tests
1
2012
120
0.020
Why?
Glutamic Acid
1
2013
210
0.020
Why?
Flow Cytometry
1
2015
1075
0.020
Why?
Suicide, Attempted
1
2014
316
0.020
Why?
Pyridines
1
2014
419
0.020
Why?
Data Collection
1
2014
618
0.020
Why?
Feasibility Studies
1
2014
735
0.020
Why?
Mood Disorders
1
2012
112
0.020
Why?
Headache
1
2012
132
0.020
Why?
Biological Specimen Banks
1
2011
94
0.020
Why?
Social Support
1
2014
528
0.020
Why?
Models, Theoretical
1
2014
513
0.020
Why?
T-Lymphocytes
1
2018
1735
0.020
Why?
Mozambique
1
2010
5
0.020
Why?
Students, Medical
1
2014
262
0.020
Why?
Pyrimidinones
1
2010
88
0.020
Why?
Antitubercular Agents
1
2011
169
0.020
Why?
North America
1
2011
255
0.020
Why?
Thalamus
1
2010
74
0.020
Why?
Mental Health
1
2015
559
0.020
Why?
Gene Expression
1
1995
1417
0.020
Why?
Multicenter Studies as Topic
1
2010
249
0.020
Why?
Statistics, Nonparametric
1
2010
384
0.020
Why?
Neuroglia
1
2010
149
0.020
Why?
Predictive Value of Tests
1
2014
1791
0.020
Why?
Organ Size
1
2010
434
0.020
Why?
Sleep Wake Disorders
1
2012
232
0.020
Why?
Caspase 7
1
2008
20
0.020
Why?
Bone Morphogenetic Protein 4
1
2008
34
0.020
Why?
In Situ Nick-End Labeling
1
2008
119
0.020
Why?
Culture Media, Conditioned
1
2008
103
0.020
Why?
Clinical Competence
1
2014
882
0.020
Why?
Caspase 3
1
2008
234
0.020
Why?
Endothelium, Vascular
1
2013
830
0.020
Why?
T-Cell Antigen Receptor Specificity
1
2006
41
0.020
Why?
Fluorides
1
2006
43
0.020
Why?
Polyurethanes
1
2006
34
0.020
Why?
Risk Assessment
1
2015
2958
0.020
Why?
gag Gene Products, Human Immunodeficiency Virus
1
2006
12
0.020
Why?
Methacrylates
1
2006
106
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2008
742
0.020
Why?
Computer Simulation
1
2010
873
0.020
Why?
Sequence Alignment
1
2006
323
0.020
Why?
Alleles
1
2007
789
0.010
Why?
Carrier Proteins
1
2008
694
0.010
Why?
Guanosine Tetraphosphate
1
1983
4
0.010
Why?
Severity of Illness Index
1
2011
2537
0.010
Why?
Light
2
1983
336
0.010
Why?
Cerulenin
1
1983
1
0.010
Why?
Linolenic Acids
1
1983
1
0.010
Why?
Linoleic Acids
1
1983
4
0.010
Why?
Oleic Acids
1
1983
10
0.010
Why?
Mice
1
2019
14843
0.010
Why?
Oleic Acid
1
1983
30
0.010
Why?
Linoleic Acid
1
1983
37
0.010
Why?
Models, Biological
1
2010
1611
0.010
Why?
Nucleotides
1
1983
112
0.010
Why?
Fatty Acids, Unsaturated
1
1983
84
0.010
Why?
Membrane Lipids
1
1983
87
0.010
Why?
Aged, 80 and over
1
2013
6306
0.010
Why?
Cytotoxicity Tests, Immunologic
1
2001
43
0.010
Why?
Bacteriological Techniques
1
1981
63
0.010
Why?
Cardiac Catheterization
1
2003
545
0.010
Why?
Apoptosis
1
2008
2349
0.010
Why?
Infant
1
2012
7943
0.010
Why?
Immunohistochemistry
1
2003
1624
0.010
Why?
Prognosis
1
2006
3315
0.010
Why?
HIV Seronegativity
1
1998
24
0.010
Why?
Substance Abuse, Intravenous
1
1998
100
0.010
Why?
Antipyrine
1
1996
3
0.010
Why?
Drug Resistance, Microbial
1
1996
66
0.010
Why?
Drug Interactions
1
1996
337
0.010
Why?
Cross-Over Studies
1
1996
439
0.010
Why?
Intracellular Membranes
1
1981
73
0.000
Why?
Cell Division
1
1981
754
0.000
Why?
Campbell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)